Jeff’s journey with Mycosis Fungoides (MF)
“It’s easy to feel overwhelmed and give up. I’m grateful to my clinical care team, family, and friends for helping me to see a path forward, that there was hope.”
See Jeff’s full storyMycosis Fungoides (MF) is the most common form of CTCL
Images of MF plaquea
aImages courtesy of Dr Oleg Akilov.
Stay ahead of your Mycosis Fungoides (MF). Talk to your doctor about receiving a blood test if you experience any new or worsening symptoms
Jeff’s journey with Mycosis Fungoides (MF)
“It’s easy to feel overwhelmed and give up. I’m grateful to my clinical care team, family, and friends for helping me to see a path forward, that there was hope.”
See Jeff’s full storyWhat is POTELIGEO®
(mogamulizumab-kpkc)?
POTELIGEO is a prescription medicine used to treat Mycosis Fungoides (MF) or Sézary Syndrome (SS) in adults who have tried at least one prior medicine (taken by mouth or injection) that did not work or in whom the disease has come back.
Important Safety Information
What is the most important information I should know about POTELIGEO?
POTELIGEO may cause serious side effects that can be severe or life-threatening including skin problems, infusion reactions, infections, autoimmune problems, and complications from stem cell transplant.
Call or see your healthcare provider right away if you develop any symptoms of the following problems or if these symptoms get worse:
What are the most common side effects of POTELIGEO?
The most common side effects of POTELIGEO include rash, tiredness, diarrhea, muscle and bone pain, and upper respiratory tract infection.
Before starting POTELIGEO treatment, tell your doctor about all your medical conditions, including whether you:
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
You are encouraged to report suspected adverse reactions to Kyowa Kirin, Inc. at 1-844-768-3544 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please see full Prescribing Information as well as Patient Information.